Cadrenal Therapeutics, Inc. Common Stock (CVKD) vs 60 Degrees Pharmaceuticals, Inc. (SXTP)

A side-by-side comparison of Cadrenal Therapeutics, Inc. Common Stock and 60 Degrees Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Cadrenal Therapeutics, Inc. Common Stock logo
CVKD
Cadrenal Therapeutics, Inc. Common Stock
$4M
$0.99HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
60 Degrees Pharmaceuticals, Inc. logo
SXTP
60 Degrees Pharmaceuticals, Inc.
$4M
$1.11HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CVKD vs SXTP

growth of $100 · dividends reinvested · last 3y
CVKD -97.2% (-69.6%/yr)SXTP -99.9% (-89.1%/yr)CVKD compounded faster over this window
Log scale — wide-divergence pair
00110100Start $100202420252026$3$0
CVKD SXTP

CVKD vs SXTP: by the numbers

  • •SXTP is the larger company ($4M vs $4M market cap).
  • •Both run net losses; CVKD's is the smaller (0.00% vs -730.23% net margin).

Metrics side by side

Valuation

MetricCVKDSXTP
P/S ratioN/A3.51
P/B ratio0.86N/A

Profitability

MetricCVKDSXTP
Gross margin0.00%19.42%
Operating margin0.00%-774.90%
Net margin0.00%-730.23%
ROE-282.13%-310.33%
ROIC-284.81%-321.28%

Growth (annualized)

MetricCVKDSXTP
Revenue CAGR (5Y)N/A-14.35%

Go deeper

Full CVKD analysisFull SXTP analysisInteractive comparison tool

Dig into the metrics

Cadrenal Therapeutics, Inc. Common Stock ROE60 Degrees Pharmaceuticals ROECadrenal Therapeutics, Inc. Common Stock operating margin60 Degrees Pharmaceuticals operating marginCadrenal Therapeutics, Inc. Common Stock revenue growth60 Degrees Pharmaceuticals revenue growthCadrenal Therapeutics, Inc. Common Stock free cash flow60 Degrees Pharmaceuticals free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.